These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17178965)

  • 21. The use of FDG-positron emission tomography for the evaluation of colorectal metastases of the liver.
    Boykin KN; Zibari GB; Lilien DL; McMillan RW; Aultman DF; McDonald JC
    Am Surg; 1999 Dec; 65(12):1183-5. PubMed ID: 10597072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early PET/CT scan is more effective than RECIST in predicting outcome of patients with liver metastases from colorectal cancer treated with preoperative chemotherapy plus bevacizumab.
    Lastoria S; Piccirillo MC; Caracò C; Nasti G; Aloj L; Arrichiello C; de Lutio di Castelguidone E; Tatangelo F; Ottaiano A; Iaffaioli RV; Izzo F; Romano G; Giordano P; Signoriello S; Gallo C; Perrone F
    J Nucl Med; 2013 Dec; 54(12):2062-9. PubMed ID: 24136935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical risk score correlates with yield of PET scan in patients with colorectal hepatic metastases.
    Schüssler-Fiorenza CM; Mahvi DM; Niederhuber J; Rikkers LF; Weber SM
    J Gastrointest Surg; 2004 Feb; 8(2):150-7; discussion 157-8. PubMed ID: 15036190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The economic impact of 18FDG positron emission tomography in the surgical management of colorectal cancer with hepatic metastases.
    Zubeldia JM; Bednarczyk EM; Baker JG; Nabi HA
    Cancer Biother Radiopharm; 2005 Aug; 20(4):450-6. PubMed ID: 16114993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of FDG-PET in surgical management of patients with colorectal liver metastases.
    Teague BD; Morrison CP; Court FG; Chin VT; Costello SP; Kirkwood ID; Maddern GJ
    ANZ J Surg; 2004 Aug; 74(8):646-52. PubMed ID: 15315564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positron Emission Tomography-Computed Tomography (PET-CT) Versus No PET-CT in the Management of Potentially Resectable Colorectal Cancer Liver Metastases: Cost Implications of a Randomized Controlled Trial.
    Serrano PE; Gafni A; Gu CS; Gulenchyn KY; Julian JA; Law C; Hendler AL; Moulton CA; Gallinger S; Levine MN
    J Oncol Pract; 2016 Jul; 12(7):e765-74. PubMed ID: 27328792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved long-term survival after resection of colorectal liver metastases following staging with FDG positron emission tomography.
    Abbadi RA; Sadat U; Jah A; Praseedom RK; Jamieson NV; Cheow HK; Whitley S; Ford HE; Wilson CB; Harper SJ; Huguet EL
    J Surg Oncol; 2014 Sep; 110(3):313-9. PubMed ID: 24737685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Routine use of positron-emission tomography/computed tomography for staging of primary colorectal cancer: does it affect clinical management?
    Cipe G; Ergul N; Hasbahceci M; Firat D; Bozkurt S; Memmi N; Karatepe O; Muslumanoglu M
    World J Surg Oncol; 2013 Feb; 11():49. PubMed ID: 23445625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Application of positron emission tomography in diagnosis of liver metastases from colorectal cancer].
    Fu CG; Wang HT; Kong LS; Cui B
    Zhonghua Wei Chang Wai Ke Za Zhi; 2005 Jan; 8(1):17-9. PubMed ID: 16148990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FDG-PET for the pre-operative evaluation of colorectal liver metastases.
    Arulampalam TH; Francis DL; Visvikis D; Taylor I; Ell PJ
    Eur J Surg Oncol; 2004 Apr; 30(3):286-91. PubMed ID: 15028310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic cryotherapy and regional chemotherapy with or without resection for liver metastases from colorectal carcinoma: how many are too many?
    Yan DB; Clingan P; Morris DL
    Cancer; 2003 Jul; 98(2):320-30. PubMed ID: 12872352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prognostic system applicable to patients with resectable liver metastasis from colorectal carcinoma staged by positron emission tomography with [18F]fluoro-2-deoxy-D-glucose: role of primary tumor variables.
    Tan MC; Castaldo ET; Gao F; Chari RS; Linehan DC; Wright JK; Hawkins WG; Siegel BA; Delbeke D; Pinson CW; Strasberg SM
    J Am Coll Surg; 2008 May; 206(5):857-68; discussion 868-9. PubMed ID: 18471711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical impact of 18F-FDG-PET in the suspicion of recurrent colorectal cancer based on asymptomatically elevated serum level of carcinoembryonic antigen (CEA) in Taiwan.
    Shen YY; Liang JA; Chen YK; Tsai CY; Kao CH
    Hepatogastroenterology; 2006; 53(69):348-50. PubMed ID: 16795969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic response to preoperative chemotherapy predicts prognosis for patients undergoing surgical resection of colorectal cancer metastatic to the liver.
    Lau LF; Williams DS; Lee ST; Scott AM; Christophi C; Muralidharan V
    Ann Surg Oncol; 2014 Jul; 21(7):2420-8. PubMed ID: 24595797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does positron emission tomography/computed tomography change management in colorectal cancer?
    Falconer R; Connor S; Balasingam A; Eglinton T
    ANZ J Surg; 2018 Apr; 88(4):E248-E251. PubMed ID: 27788564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FDG PET in preoperative assessment of colorectal liver metastases combining "evidence-based practice" and "technology assessment" methods to develop departmental imaging protocols: should FDG PET be routinely used in the preoperative assessment of patients with colorectal liver metastases?
    Sheehan JJ; Ridge CA; Ward EV; Duffy GJ; Collins CD; Skehan SJ; Malone DE
    Acad Radiol; 2007 Apr; 14(4):389-97. PubMed ID: 17368206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluating 90Y-glass microsphere treatment response of unresectable colorectal liver metastases by [18F]FDG PET: a comparison with CT or MRI.
    Wong CY; Salem R; Raman S; Gates VL; Dworkin HJ
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):815-20. PubMed ID: 12029557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical value of whole-body emission tomography in potentially curable colorectal liver metastases.
    Topal B; Flamen P; Aerts R; D'Hoore A; Filez L; Van Cutsem E; Mortelmans L; Penninckx F
    Eur J Surg Oncol; 2001 Mar; 27(2):175-9. PubMed ID: 11345944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of local control after laser-induced thermotherapy of liver metastases from colorectal cancer: contribution of FDG-PET in patients with clinical suspicion of progressive disease.
    Denecke T; Steffen I; Hildebrandt B; Rühl R; Streitparth F; Lehmkuhl L; Langrehr J; Ricke J; Amthauer H; Hänninen EL
    Acta Radiol; 2007 Oct; 48(8):821-30. PubMed ID: 17924212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colorectal cancer recurrence in the liver: detection by PET.
    Yasuda S; Makuuchi Y; Sadahiro S; Mukai M; Tokunaga N; Tajima T; Shohtsu A
    Tokai J Exp Clin Med; 1998 Oct; 23(4):167-71. PubMed ID: 10359505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.